Patents by Inventor Hitomi KONDO

Hitomi KONDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHENOL COMPOUND OR SALT THEREOF
    Publication number: 20230049402
    Abstract: The present invention provides a phenol compound represented by the following Formula (I) or a salt thereof: wherein R1, R2, R5, L1, L2, L3, A, X, and m are as described in the specification.
    Type: Application
    Filed: December 6, 2019
    Publication date: February 16, 2023
    Inventors: TOSHIHIRO SAKAMOTO, HIDEKI KAZUNO, HITOMI KONDO, TOMOHIRO YAMAMOTO, TETSUYA SUGIMOTO
  • 4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF
    Publication number: 20230023023
    Abstract: The present invention provides an antitumor agent comprising a compound or a pharmaceutically acceptable salt thereof that covalently binds to GTP-bound KRASG12C as an active ingredient.
    Type: Application
    Filed: October 29, 2020
    Publication date: January 26, 2023
    Inventors: KAZUAKI SHIBATA, YUICHI KAWAI, HIROKI ASAKURA, TETSUYA SUGIMOTO, NAOKI EGASHIRA, TOMOHIRO YAMAMOTO, TATSUYA SUZUKI, YUKI KATAOKA, TAKESHI SAGARA, TOSHIHIRO SAKAMOTO, HITOMI KONDO, CHRISTOPHER CHARLES FREDERICK HAMLETT, PATRICK SCHÖPF, DAVID GEOFFREY TWIGG
  • NOVEL INDAZOLE COMPOUND OR SALT THEREOF
    Publication number: 20210395234
    Abstract: An indazole compound represented by the following Formula (I) or a salt thereof: wherein X, R1, R2, ring A, L1, L2, L3, and R5 are as defined in this specification.
    Type: Application
    Filed: October 25, 2019
    Publication date: December 23, 2021
    Inventors: TOSHIHIRO SAKAMOTO, HIDEKI KAZUNO, TETSUYA SUGIMOTO, HITOMI KONDO, TOMOHIRO YAMAMOTO
  • Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof
    Patent number: 10174040
    Abstract: A pyrrolopyrimidine compound or a salt thereof and compositions, NAE inhibitors and anti-tumor agents containing the pyrrolopyrimidine compound or a salt thereof.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: January 8, 2019
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Takashi Mizutani, Chihoko Yoshimura, Hitomi Kondo, Makoto Kitade, Shuichi Ohkubo
  • PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF AND COMPOSITIONS CONTAINING THE PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF
    Publication number: 20180162864
    Abstract: A pyrrolopyrimidine compound or a salt thereof and compositions, NAE inhibitors and anti-tumor agents containing the pyrrolopyrimidine compound or a salt thereof.
    Type: Application
    Filed: February 7, 2018
    Publication date: June 14, 2018
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Takashi MIZUTANI, Chihoko YOSHIMURA, Hitomi KONDO, Makoto KITADE, Shuichi OHKUBO
  • Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof
    Patent number: 9963456
    Abstract: A pyrrolopyrimidine compound or a salt thereof and compositions, NAE inhibitors and anti-tumor agents containing the pyrrolopyrimidine compound or a salt thereof.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: May 8, 2018
    Assignee: Taiho Pharmaceutical Co., Ltd
    Inventors: Takashi Mizutani, Chihoko Yoshimura, Hitomi Kondo, Makoto Kitade, Shuichi Ohkubo
  • NOVEL PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ESPECIALLY AGENT FOR PREVENTION AND/OR TREATMENT OF TUMORS ETC BASED ON NAE INHIBITORY EFFECT
    Publication number: 20170066772
    Abstract: An object to be solved by the present invention is to provide a novel pyrrolopyrimidine compound or a salt thereof having an NAE inhibitory action and a cell growth inhibitory effect. The present invention provides a compound or a salt thereof represented by Formula (A), as well as an NAE inhibitor, a pharmaceutical composition, and an antitumor agent comprising the compound or a salt thereof as an active ingredient.
    Type: Application
    Filed: June 24, 2015
    Publication date: March 9, 2017
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Takashi MIZUTANI, Chihoko YOSHIMURA, Hitomi KONDO, Makoto KITADE, Shuichi OHKUBO